NUNZ — Nunzia Pharmaceutical Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.15m
Annual balance sheet for Nunzia Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | — | — | — | — | 0 |
| Total Current Assets | — | — | — | — | 0 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0 | 0 | 0 | 0 | 0.005 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.262 | 0.275 | 0.294 | 0.036 | 0.099 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.262 | 0.275 | 0.294 | 0.059 | 0.099 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.262 | -0.275 | -0.294 | -0.059 | -0.094 |
| Total Liabilities & Shareholders' Equity | 0 | 0 | 0 | 0 | 0.005 |
| Total Common Shares Outstanding |